Triple therapy AMD trial to continue

Article

The Phase II RADICAL study (Reduced Fluence Visudyne Anti-VEGF-Dexamethasone In Combination for AMD Lesions) is to continue as planned, following promising interim results and the positive recommendations of the independent Data and Safety Monitoring Committee.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
Related Content
A sign in front of palm trees. It reads "Welcome to Florida: The Sunshine State." Concept image for American Academy of Ophthalmology 2025 meeting in Orlando, Florida. Image credit: ©quasarphotos – stock.adobe.com

What to expect at the American Academy of Ophthalmology meeting

Lynda Charters
October 12th 2025
Article
PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

October 12th 2025
Podcast
A child's face, in profile, next to a Snellen chart. Concept image for atropine use in paediatric patients with myopia and long-term effects or complications of atropine and red light therapy. Image credit: ©New Africa – stock.adobe.com

Insights into atropine usage

Lynda Charters
October 12th 2025
Article
PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

October 12th 2025
Podcast
A lectern and podium, with three microphones, in front of the European Union (EU) flag. Concept image for Ophthalmology Times Europe editorial advisory board members presenting at American Academy of Ophthalmology meeting 2025. Image credit: ©corund – stock.adobe.com

AAO 2025: What the Eye Care Network's editorial advisory board members are presenting

Kassi Filkins
October 12th 2025
Article
Site Logo

Complex Glaucoma Management: From Anterior to Posterior Segment

October 12th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.